Article info
PDFEditorial commentary
Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy
- Correspondence to Dr Hiroshi Mitsumoto, Department of Neurology, Columbia University Medical Center, New York, USA; hm264{at}columbia.edu
Citation
Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy
Publication history
- Received June 12, 2017
- Accepted June 13, 2017
- First published August 9, 2017.
Online issue publication
December 12, 2017
Article Versions
- Previous version (12 December 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.